Tech Center 1700 • Art Units: 1631 1653 1798 1799
This examiner grants 71% of resolved cases
Ashley Nicole Lopezlira is an examiner in Art Unit 1631 within Tech Center 1700. The examiner has overseen 52 resolved cases, resulting in an allowance rate of 71.2 percent. This rate indicates a generally positive outcome for applicants who reach a final resolution in this unit. Practitioners can use this 71.2 percent figure to benchmark the likelihood of success during the prosecution phase.
The data shows a significant interview lift of 42.0 percent. This suggests that engaging in an interview is a highly effective strategy for overcoming rejections. The 42.0 percent lift implies that direct communication with the examiner often clarifies technical issues or claim scope, leading to a more favorable result than written responses alone.
The median days to allowance for this examiner is 1379. This timeline provides a clear expectation for the duration of the patent acquisition process. While the 1379-day median reflects a multi-year commitment, the high interview lift offers a potential avenue for practitioners to manage the prosecution more efficiently. Understanding these metrics allows for better strategic planning and client communication.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18692663 | POLYSTYRENE COATED CELL CULTURE SUBSTRATES, FIXED BED BIOREACTORS, AND RELATED METHODS | Non-Final OA | CORNING INCORPORATED |
| 18476464 | ORGAN CROSSTALK IN VITRO CHAMBER TO SIMULATE MULTI ORGAN TISSUES | Final Rejection | Government of the United States as represented by the Secretary of the Air Force |
| 18687653 | CELL CULTURING DEVICE | Non-Final OA | SHIMADZU CORPORATION |
| 17684884 | APPARATUS AND METHOD FOR GENE AMPLIFICATION | Final Rejection | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 17762823 | BIOREACTOR CHAMBER | Non-Final OA | Oxford University Innovation Limited |
| 18548455 | DEVICE WITH AN INSERT FOR TREATING CELL MATERIAL | Non-Final OA | Bühler AG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy